Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, March 28, 2024 · 699,409,026 Articles · 3+ Million Readers

High-Throughput Flow Cytometry Is An Emerging Market Trend In The Cytometry Global Market

Flow Cytometry  Market Report 2021: COVID-19 Growth And Change To 2030

Flow Cytometry Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Flow Cytometry Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, April 19, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

High-throughput flow cytometry is an emerging trend in the flow mass cytometry market. This is due to high speed of cell parameter processing and capability to analyze several heterogeneous cell groups at once, using this technique. Traditional cytometry methods are very slow, especially when several cells need to be tested within a day. Using high-throughput flow cytometry methods such as fluorescence-activated cell-sorting (FACS), multiple cells can be allotted fluorescent markers which can be used to analyze their parameters in quick time. Examples of companies that offer high-throughput flow cytometry solutions include AstraZeneca and Novartis.

Other flow cytometry market trends include mergers and acquisitions. In February 2019, Danaher acquired the biopharma business of GE Life Sciences for $21.4 billion. This acquisition will help Danaher to improve its existing bioprocessing capabilities. The biopharma division of GE Life Sciences is involved in the development and production of biologic drugs, vaccines and cell therapies. It develops products and solutions that facilitate research into fundamental cell and protein biology. GE Life Sciences is a division of GE Healthcare, which was founded in 1994 and has its headquarters in Illinois, the USA.

Major players in the flow cytometry industry are Beckman Coulter, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher and Luminex.

Read More On The Global Flow Cytometry Market Report:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

The global flow cytometry market is expected to grow from $4.11 billion in 2020 to $4.52 billion in 2021 at a compound annual growth rate (CAGR) of 10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The flow cytometry market is expected to reach $6.07 billion in 2025 at a CAGR of 7.6%. The countries with flow cytometry market shares are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The flow cytometry market covered in this report is segmented by type into instruments, reagents & consumables, software, accessories, services. The market is also segmented by technology into cell-based, bead-based flow cytometry market, by end user into hospitals and clinics, academia and research institutes, pharmaceutical and biotechnology companies, other end users, by application into oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology.

Flow Cytometry Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides flow cytometry global market overview, forecast flow cytometry global market size and growth for the whole market, flow cytometry market segments, and geographies, flow cytometry market trends, flow cytometry market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Flow Cytometry Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2509&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Research Antibodies and Reagents Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/research-antibodies-and-reagents-global-market-report-2020-30-covid-19-growth-and-change

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2021: COVID-19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-change

Cell Based Assays Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release